# Autonomous Agentic Afternoon Scan — 2026-08-19

- Timestamp: 2026-08-19 17:31 UTC / 13:31 ET
- Account: Robinhood Agentic ••••1041 (433711041) only
- Mode: pre-authorized autonomous equities-only operation
- Policy: `playbook/autonomous-policy.md` ACTIVE; no date-specific trading plan found
- Decision: **HOLD MA, SHOP, BAC; NO NEW ORDER / NO ROTATION**

## Broker and kill-switch verification

- Broker returned account active, cash, `agentic_allowed=true`; no other account was operated.
- Account value: $327.63, safely above the $10 kill switch.
- Equity value: $257.84; cash and authoritative buying power: $69.79; unsettled funds: $0.
- Positions: MA 0.113541 @ $572.48; BAC 1.046363 @ $62.12; SHOP 0.862075 @ $144.09. All quantities are available to sell.
- Open-ish order states checked independently: new, queued, confirmed, unconfirmed, partially_filled — all empty.
- Recent fills query (since 2026-08-12) showed only the previously journaled AVGO sale on Aug. 17 and NESR sale on Aug. 12; no fill today.
- Pending commitment: $0. Liquid buying power after pending orders: $69.79. Policy slice: $55.83 deployable (80%); $13.96 required reserve (20%). Existing equity deployment is 78.70% of account value and cash is 21.30%.
- Existing marked risk to current management stops is approximately $8.38, above the default $6 aggregate target. No stop was widened and no new risk was added.

## Regime and macro/sector context

- **Mixed/rotation.** At 13:31 ET: SPY $769.60 (+0.28%), QQQ $716.57 (-0.13%), IWM $301.90 (+0.56%). Prior-close structures: SPY and IWM above SMA20/SMA50; QQQ above SMA20 but only marginally above/near SMA50.
- Sector tape: XLV +3.09% and XLY +1.80% led; XLK -0.95% lagged; XLF -0.15% and XLE flat. This favors selective health/consumer strength while arguing against chasing expensive technology momentum.
- Treasury buyback headlines helped stabilize bonds and equities, but yields/oil/inflation remain macro risks. FOMC minutes were due at 14:00 ET, 29 minutes after this snapshot, so adding risk immediately before the release was not justified.

## Position management ranking

1. **MA — HOLD, 13/16.** Mark $575.55; value ~$65.35; unrealized +$0.35. Above rising SMA20 $561.94 and SMA50 $532.52; 20/60-day momentum +6.7%/+14.9%. Intraday high $582.93 faded, but price remains above support. Stop/invalidation $564; targets $594/$602. Marked risk ~$1.31. Profitable, high-quality payments business; no add while financials lag.
2. **SHOP — HOLD/protect, 12/16.** Mark $146.53; value ~$126.32; unrealized +$2.10. Strong 20/60-day momentum (+19.1%/+39.8%), above rising SMA20/50, and latest verified EPS $0.42 beat $0.37. XLY leadership supports the thesis, but ~99x trailing P/E and the fade from $149.78 argue against adding. Stop $140; targets $158.87/$166. Marked risk ~$5.63.
3. **BAC — HOLD, weakest, 10/16.** Mark $63.28; value ~$66.21; unrealized +$1.21. Long trend remains above SMA20 $62.93/SMA50 $60.04 with +4.9%/+24.7% 20/60-day momentum; Q2 EPS $1.21 beat $1.11 and valuation is moderate (~14.8x). However, BAC fell 1.48% while XLF was nearly flat and traded near $63.12 support. Stop/invalidation remains $61.90; first reassessment trigger is a decisive loss of $62.90 without recovery; targets $65.23/$67. Marked risk ~$1.44. Do not average down.

## Ranked fresh candidates

1. **LLY — 13/16, WATCH/RETEST, not entry-confirmed.** $1,268.58 (+3.50%), XLV leadership, above SMA20/50 ($1,186/$1,173), +4.3%/+17.7% 20/60-day momentum, and verified Q2 EPS $8.38 vs $6.01. It set a new 52-week high at $1,292.65 but faded ~$24 from the high; bid/ask was unusually wide around the snapshot. Require an orderly hold/retest near $1,240–1,250; stop ~$1,218; targets $1,300/$1,335. No pre-FOMC chase.
2. **XOM — 12/16, WATCH.** $166.03 (+0.28%), above SMA20/50 ($156.94/$148.07) and just above prior $165.67 breakout resistance; +9.1%/+6.6% momentum. Profitable, liquid, 2.46% yield, but latest verified EPS $3.52 missed $3.76 and XLE was flat after an intraday fade from $168.21. Require a confirmed hold/retest of $165.5–166; stop $160.8; targets $174/$179.
3. **ABBV — 11/16, WATCH.** $263.12 (+1.62%) with XLV leadership, above SMA20/50 ($252.13/$245.60), but below $267.47 resistance and with only ~45% of typical daily volume by 13:31. Require breakout and retest above $267.50; stop $259; targets $281/$289.
4. **EL — 11/16, WAIT FOR BASE.** $98.65 (+17.06%), verified EPS $0.39 vs $0.32, and ~3.5x typical full-day volume already. However, it is loss-making on a trailing basis, nearly 6 ATR above the prior SMA20, and therefore disqualified as an extended gap chase. Watch a multi-session base/retest near $94–96.
5. **PLTR — 10/16, WATCH ONLY.** $173.90 (+1.38%), powerful +29.3%/+24.8% momentum, but XLK lagged, valuation is ~147x earnings, and price faded from $176.82. Only consider a controlled $171–173 retest with a $166 stop and $185/$194 targets after macro confirmation.

TEM (+21.7%), TWST (+18.0%), MRNA (+148.9%), and BNTX (+19.9%) were rejected as extended/speculative entries despite strong volume or catalysts. Their current structures do not offer controlled swing invalidation without chasing.

## Action, deployment, and order record

- **Action:** hold all three positions; no add, trim, exit, cancellation, or rotation.
- **Order reviews:** none. No candidate cleared both the confirmed-entry gate and aggregate-risk gate; a broker preview cannot repair an extended or pre-event entry.
- **Orders placed / fills:** none; exact new deployment $0.00.
- **Cash after action:** $69.79. Required reserve: $13.96. The $55.83 nominal deployable slice remains unspent because the no-force, macro-event, and aggregate-risk controls bind.
- Next triggers: reassess/exit BAC on decisive loss of $62.90 and especially $61.90; SHOP below $140; MA below $564. Do not widen stops or average down. Recycle proceeds only into a confirmed higher-scoring setup.
